What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Acute Myeloid Leukemia
Proceedings from a live event on December 6, 2024, part of a Friday Satellite Symposia program preceding the American Society of Hematology (ASH) Annual Meeting. Featuring perspectives from Dr Alexander Perl, Dr Eytan M Stein, Dr Richard M Stone, Dr Eunice S Wang and Prof Andrew H Wei, moderated by Dr Stein. Published January 6, 2025.
Topics:
• Introduction (0:00)
• Treatment for Older Patients with Acute Myeloid Leukemia (AML) — Prof Wei (2:48)
• Selection of Initial Therapy for Younger Patients with AML without a Targetable Mutation, Including Those with Secondary AML — Dr Stone (26:52)
• Role of FLT3 Inhibitors in AML Management — Dr Perl (49:41)
• Incorporation of IDH Inhibitors into the Care of Patients with AML — Dr Stein (1:13:57)
• Potential Role of Menin Inhibitors and Other Novel Agents in the Treatment of AML — Dr Wang (1:35:50)
The entire program, slides, CME information, and select publications:
[ Ссылка ]
